13 Days, 250K in OIG Fines

Posted by Frank Strafford on February 5, 2015 in Industry News, OIG Penalties,

Looks like the OIG means business.

13 Days, 250K in OIG FinesOver the course of the past 13 days, over $250,000 in fines have been meted out due to the alleged employment of excluded individuals.  The first involved a Minnesota pharmacist who owned and managed a pharmacy that participated in Federal health care programs while he was excluded from participating in these programs.  The second involved an Alabama hospital which employed an individual who was excluded from participating in any Federal health care programs.  And the third involved a group home in Arizona, which had employed a nurse who has been excluded from participation in Federal health care programs.

Three different states; three different types of providers; three different fields of employment.

All nailed under the same exclusion mandate.

Points to ponder:

  • The excluded individual at the Alabama facility was identified through ‘a data analysis project initiated by the OIG’s Office of Evaluation and Inspections’.  The OIG post and website make no mention of when, how, and why this data analysis project was launched; nor of how extensive it is, and which providers are earmarked for future data analyses.
  • Penalties extended across several states and types of facilities; nobody appears to be immune.

Employers take note.

About Frank Strafford

About Frank Strafford

Related Articles

Infographic: 2017 OIG Exclusions & Penalties

December 20, 2017

In 2017, the HHS Office of the Inspector General (OIG) remained active in detecting Medicare and Medicaid provider violations, resulting in fines or settlements and exclusions from participation. Ther...

Feds Pressuring States to Step Up ...

May 7, 2015

When the Federal OIG threatens to enforce exclusion, they mean business.  Pronto. The Federal OIG's Ohio State Medicaid Fraud Control Unit: 2014 Onsite Review slaps the Ohio State Unit on the ground...

New Antibody Testing Follow-on Study

July 16, 2020

On the heels of the NIH-supported Expanded Access Program (EAP) for Convalescent Plasma, a secondary antibody testing modality has been developed as part of the Antibody Everybody initiative powered b...